LIVE

ECVT

Ecovyst Inc.

ECVT

NYSE·Basic Materials·Chemicals - Specialty·Mkt cap $1.3B

$11.83

-1.42%

View full research view

Our plain-language verdict, the thesis, risk factors, and what is changing about the business.

View research view

52-Week Range

$7.41 - $15.09

P/E

83.02

Fwd P/E

17.98

Beta

1.06

Div Yield

0.00%

Avg Vol

2.0M

Shares Out

110.6M

Mkt Cap

$1.3B

Price action

Price chart

Up 44.6% over the trailing year

1W
1M
3M
6M
YTD
1Y
5Y
MAX

Total returns

Price performance

Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.

Why we rate it this way

The thesis at a glance

Bull and bear case · plain-English context across the five lenses we evaluate.

Bull Case

4 reasons

  • 190+ year heritage and established relationships with major refineries and chemical producers
  • Proprietary catalyst technology and customized process solutions for polyethylene and MMA production
  • Integrated sulfuric acid recycling and supply chain reducing customer costs and environmental impact
  • Specialized expertise in emission control catalysts meeting stringent environmental regulations

Bear Case

1 risk

  • Average volatility.

Growth

Moderate growth ahead

Increasing demand for sustainable refining solutions and sulfuric acid recycling services

Value

Fairly valued vs Specialty Chemicals peers

Momentum

Weak

-8.0% over 3m

Quality

Stable

Strong fundamentals

Dividend

None

No dividend

Earnings track record

Latest print - beat on both lines

AI-summarized recap of last quarter, plus the surprise on every print.

Next: Apr 29, 2026

Q2 26 RECAP

MAY 5, 2026

Reported EPS of $0.11 vs $0.07 consensus (+57.1% surprise). Revenue of $215.0M vs $191.1M expected (+12.5%). Beat on both top and bottom lines.

EPS beat +57.1%
Rev beat +12.5%
Double beat

EPS surprise · last 4Q

1 of 1 beats

Q2 26

+57.1%

Next: Apr 29, 2026

Revenue trend · last 8Q

+5%

+1%

+9%

+14%

+10%

+33%

Q2 24

Q3 24

Q4 24

Q1 25

Q2 25

Q3 25

Q4 25

Q1 26

$182.8M

$179.2M

$182.0M

$162.2M

$200.1M

$204.9M

$199.4M

$215.0M

Margins · last 8Q

Gross

Operating

Profit

2.0%

Wall Street consensus

3 analysts · 100% Buy

Live ratings and price targets aggregated across covering analysts.

Buy

3

100%

Hold

0%

Sell

0%

Median Price Target

Latest: Citi · Jun 24, 2026

vs Industry

How ECVT stacks vs Chemicals - Specialty

Stock metrics vs industry averages. Green = better than industry.

Industry comparison data unavailable for this stock.